Japan's Takeda Reportedly Offering $12B For Europe's Nycomed
This article was originally published in PharmAsia News
Executive Summary
Japan's largest drug maker, Takeda Pharmaceuticals Co. Ltd., may be close to buying private-equity owned Nycomed AS, based in Switzerland, for about $12 billion